Ginkgo bioworks awarded darpa contract to reimagine the manufacturing of complex therapeutic proteins

Arlington, va. and boston , july 19, 2023 /prnewswire/ -- approved for public release, distribution unlimited — the defense advanced research projects agency ( darpa ) announced that ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, has been awarded a 4-year contract worth up to $18 million to reimagine how to manufacture complex therapeutic proteins.
DNA Ratings Summary
DNA Quant Ranking